Comparison of the efficacy of intravitreal ranibizumab for choroidal neovascularization due to pathological myopia with and without a dome-shaped macula

Ranibizumab injection in the treatment of choroidal neovascularization (CNV) secondary to pathologic myopia (PM) with and without a dome-shaped macula (DSM). Prospective observational study. A total of 24 patients (24 eyes) with angiographic evidence of CNV secondary to PM were divided into 2 groups...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Bincui, Yang, Jin, Li, Shuang, Wang, Linni, Chen, Lu, Li, Xiaorong, Li, Zhiqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
5800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815773/
https://www.ncbi.nlm.nih.gov/pubmed/29390361
http://dx.doi.org/10.1097/MD.0000000000009251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815773/
https://www.ncbi.nlm.nih.gov/pubmed/29390361
http://dx.doi.org/10.1097/MD.0000000000009251

Ejemplares similares